GLPwatch
IDegLira: combining efficacy, durability, and convenience?
Lancet Diabetes Endocrinol · 2019
Last updated 2026-09-22| Journal | Lancet Diabetes Endocrinol, 2019 |
|---|---|
| Citations | 2 |
| Relative citation ratio | 0.10 |
| NIH percentile | 7 |
| Molecules | — |
| Conditions studied | Type 2 Diabetes, Obesity |
Full record and abstract on PubMed 31189518 ↗